FDA Drugs recall ·
Levothyroxine Sodium Tablets, USP, Thyro-Tabs, 150mcg, 1000 Tablets… recall
- Recall number
- D-0259-2026
- Date
- (initiated December 31, 2025)
- Company / brand
- Alvogen, Inc
44 Whippany Rd Ste 300, Morristown, NJ, United States - Category
- Drugs › Class II
- Classification
- Class II
- Status
- Ongoing
- Initiated by
- Voluntary: Firm initiated
Read the official FDA notice ↗
Product
Levothyroxine Sodium Tablets, USP, Thyro-Tabs, 150mcg, 1000 Tablets, Rx only, Manufactured by: LLOYD, Inc., Shenandoah, IA, 51601 USA, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058 USA, NDC: 47781-662-10.
Why was it recalled?
Product Mix-Up: A single bottle of this lot was reported by a pharmacy to contain 88 mcg tablets instead of 150 mcg tablets.
What should you do?
FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.
Product codes & lot numbers
Lot # MHA21825, Exp Date: December 31, 2027
Distribution
US Nationwide.
What does Class II mean?
Class II means use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious harm is remote.
Source: FDA (drugs), recall D-0259-2026. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.